[Elsevier] Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial |
|
This post will be closed automatically in 2026-09-18 22:52
Reward10points
|
50
[Full book]Hydrogels for Wound Healing
40
Denosumab Use in Adults With Fibrous Dysplasia: Case Reports and Review of the Literature
10
Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial
10
Deep learning-based travel choice prediction with provable and adaptable fairness guarantees
10
Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial
